InvestorsObserver
×
News Home

Is Organogenesis Holdings Inc (ORGO) Stock a Good Buy on Thursday?

Thursday, May 28, 2020 03:42 PM | InvestorsObserver Analysts

Mentioned in this article

Is Organogenesis Holdings Inc (ORGO) Stock a Good Buy on Thursday?

Overall market sentiment has been down on Organogenesis Holdings Inc (ORGO) stock lately. ORGO receives a Bearish rating from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bearish
Organogenesis Holdings Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ORGO!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.

Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.

InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.

Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With ORGO Stock Today?

Organogenesis Holdings Inc (ORGO) stock is trading at $4.55 as of 3:40 PM on Thursday, May 28, a rise of $1.09, or 31.5% from the previous closing price of $3.46. Volume today is above average. So far 2,982,219 shares have traded compared to average volume of 86,754 shares. The stock has traded between $3.63 and $4.78 so far today.

To screen for more stocks like Organogenesis Holdings Inc click here.

More About Organogenesis Holdings Inc

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App